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Editorial on the Research Topic
Ion Channel Trafficking and Cardiac Arrhythmias
The cardiac action potential is one of the most exquisite examples of regulated protein expression
that nature presents. The balanced expression of many underlying channel proteins that transport
ions with great selectivity at the sarcolemma of cardiomyocytes is crucial to maintain regular
cardiac contraction throughout one’s lifetime. The coordinated expression must display both
robustness and flexibility to sustain stability in action potential generation during homeostasis and
rapid adaptation in response to altered physiological demands. Moreover, regional differences in
action potential shape within the heart allude to the tuning and fine tuning of functional ion channel
expression at the sarcolemma.
The cellular processes that transport channel proteins from the endoplasmic reticulum toward
specified regions on the sarcolemma and, subsequently, remove them from the plasma membrane
and direct them to the protein degradation machinery are commonly known as trafficking.
Recycling and additional intracellular transport mechanisms are contained within this definition.
Importantly, several forms of congenital long QT syndrome result from the aberrant trafficking
of ion channels. For example, many mutations in the KCNH2 gene, encoding the Kv11.1 (hERG)
potassium channel, result in incomplete glycosylation and decreased levels of functional expression
at the sarcolemma (Anderson et al., 2014). In addition, drugs that induce arrhythmia also disturb
normal trafficking and, hence, alter cardiac electrophysiology (de Git et al., 2013). Finally, cardiac
remodeling processes that are associated with cardiac disease also affect the trafficking of ion
channels and gap junction proteins (Basheer and Shaw, 2016).
Research on ion channel trafficking is complex as it requires a multidisciplinary approach that
combines a plethora of techniques that include molecular biology and cell biology, biochemistry,
imaging, and electrophysiology to name a few. Furthermore, the field of cardiac ion channel
trafficking is challenged to apply new concepts from basic cell biology that focus on the general
structure and basic mechanisms of intracellular transport toward the level of individual ion
channels.
It is the purpose of this Frontiers Research Topic on ion channel trafficking and cardiac
arrhythmias to reveal some new levels of complexity and to implicitly provide new directions that
the field must explore.
Balse and Boycot provide a review on the basic mechanisms of ion channel trafficking,
their interdependence on basal cellular (e.g., local lipid composition) and extracellular (e.g.,
potassium concentration) factors, and some examples of modifying ion channel trafficking in
order to counteract arrhythmias. The role of anchoring proteins in steering channel trafficking
and membrane localization and their involvement in human cardiac disease is described in
the review by El Refaey and Mohler. Thereafter, the role of non-pore-forming Nav-β-subunits
channel proteins in trafficking of sodium and also the potassium channels and their importance
in normal channel distribution within the cardiomyocyte are discussed by Edokobi and Isom. In
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their perspective paper, Van Bavel et al. emphasize on the
involvement of autophagy pathways in cardiac ion channel
trafficking under disease conditions and the impact of drugs,
including antiarrhythmics, on autophagy and subsequent
arrhythmic outcomes.
The development of a single cell high-throughput system
to detect aberrant Kv11.1 trafficking is the aim of the original
contribution by Kanner et al. An important implication of their
findings is that full glycosylation of the Kv11.1 protein is not,
by definition, equal to plasma membrane localization. Hall et al.
provide compelling evidence for mutation specific differences
in Kv11.1 trafficking defects, that is, variations in intracellular
retention, which may have consequences for future treatment
options. Importantly, they also demonstrate that the findings
obtained in HEK293 cells can be replicated in cardiomyocytes
derived from human induced pluripotent stem cells.
Ion channel interdependence with respect to expression and
function is the focus of the original contributions by Utrilla
et al. and Portero et al. The trafficking properties of the Kir2.1-
Nav1.5 channel complex are different from those of the individual
channels. Utrilla et al. found the dominance of Nav1.5 over Kir2.1
with respect to regulation of internalization, CamKII sensitivity,
and degradation. Portero et al. demonstrate the impact of
Kv4.3 channel expression on the Nav1.5 current in an ectopic
expression system and how this may relate to gain-of-function
mutations in the Kv4.3 coding gene in Brugada syndrome. Both
studies demonstrate the importance of studying the trafficking
of a single channel in the context of other channel types. In
view of the balanced channel expression required to generate a
cardiac action potential, such channel complex formation and
interdependence may not come as a surprise.
Bianchi et al. describe newmutations in TRPM4 channels that
are associated with complete heart block or idiopathic ventricular
fibrillation and found that the gain- and loss-of-expression is
directly related to differences in protein stability in the plasma
membrane. Taneja et al. build upon their earlier work on Kir2.1
anterograde transport (Li et al., 2016) and provide evidence
that the Golgi-tether Golgin-97 is involved in Kir2.1 transport
through the Golgi apparatus to reach the trans-Golgi-network.
Finally, Fu et al. identified an additional function of the
connexin 43 isoform GJA1-20k. This connexin 43 isoform
increases in expression upon cellular stress, promotes
mitochondrial transport along the microtubules, and preserves
normal cellular localization of the mitochondria. This study
also implicates that ion channel proteins can have additional
“noncanonical” cellular functions apart from ion conduction
across the plasma membrane. From a physiological point
of view, we anticipate that adaptations in action potential
features and expression of their underlying ion channels may
have direct impact on a number of cellular processes and
signaling mechanisms that are initiated by the channel proteins
themselves.
Several lessons can be taken from this Frontiers Research
Topic. (1) Ion channel trafficking is of great complexity in which
each channel protein type follows its own specific path, and even
different mutations within the same protein can affect different
steps. (2) Ion channel complexes exhibit different trafficking
properties when compared to their individual components. (3)
Ectopic expression of one channel protein type reveals intrinsic
trafficking properties that can be reproduced in cardiac cell types,
but full appreciation of trafficking behavior in view of action
potential properties may require co-expression of additional
channel types. (4) Channel proteins are versatile and have
additional cellular functions, apart from conducting ions across
the plasmamembrane, in intracellular signaling and in regulating
subcellular architecture.
Finally, the field of cardiac ion channel trafficking is
progressing rapidly. As indicated by several authors in this
Frontiers special issue, now the field has to progress from
ectopic cell systems toward adult cardiomyocytes. Furthermore,
we encourage the study of channel trafficking in vivo to
unequivocally determine the direct link between aberrant ion
channel trafficking and cardiac arrhythmia.
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